
Quarterly report 2023-Q3
added 12-12-2023
Akumin Market Cap 2011-2025 | AKU
As of December 25, 2025 Akumin has a market cap of $ 25.9 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Akumin
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 75.1 M | 83 M | 221 M | 311 M | 256 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 311 M | 75.1 M | 189 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M | ||
|
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | ||
|
Brainsway Ltd.
BWAY
|
240 M | $ 19.29 | -1.73 % | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
709 M | $ 40.09 | -0.27 % | $ 1.11 B | ||
|
Burning Rock Biotech Limited
BNR
|
2.95 B | $ 21.26 | -2.34 % | $ 229 M | ||
|
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | ||
|
Danaher Corporation
DHR
|
152 B | $ 231.47 | 0.28 % | $ 169 B | ||
|
DarioHealth Corp.
DRIO
|
43.4 M | $ 10.04 | -0.99 % | $ 285 M | ||
|
DexCom
DXCM
|
48.8 B | $ 67.42 | 0.84 % | $ 26 B | ||
|
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | ||
|
BioNano Genomics
BNGO
|
3.55 M | $ 1.52 | -0.65 % | $ 1.93 M | ||
|
Exact Sciences Corporation
EXAS
|
9.32 B | $ 101.54 | -0.05 % | $ 18.8 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M | ||
|
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | ||
|
Fulgent Genetics
FLGT
|
467 M | $ 27.01 | -0.55 % | $ 817 M | ||
|
Global Cord Blood Corporation
CO
|
243 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.54 B | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
521 M | $ 19.73 | -1.45 % | $ 1.06 B | ||
|
Celcuity
CELC
|
399 M | $ 102.61 | 0.25 % | $ 4.05 B | ||
|
Anixa Biosciences
ANIX
|
70.8 K | $ 3.42 | 3.64 % | $ 109 K | ||
|
Co-Diagnostics
CODX
|
34.9 M | $ 0.24 | -1.79 % | $ 7.04 M | ||
|
IQVIA Holdings
IQV
|
35.7 B | $ 226.02 | 0.39 % | $ 41 B | ||
|
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K | ||
|
Guardant Health
GH
|
5.84 B | $ 102.38 | -0.12 % | $ 12.6 B | ||
|
NeoGenomics
NEO
|
1.53 B | $ 12.3 | -0.97 % | $ 1.56 B | ||
|
Neogen Corporation
NEOG
|
1.02 B | $ 7.14 | -0.14 % | $ 1.55 B | ||
|
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M | ||
|
National Research Corporation
NRC
|
1.01 B | $ 18.81 | -1.05 % | $ 462 M | ||
|
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | ||
|
Organovo Holdings
ONVO
|
3.1 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
9.12 M | - | -16.95 % | $ 1.54 M | ||
|
OPKO Health
OPK
|
1.21 B | $ 1.3 | -0.76 % | $ 902 M | ||
|
Mettler-Toledo International
MTD
|
29.9 B | $ 1 417.16 | 0.18 % | $ 30.1 B | ||
|
Illumina
ILMN
|
16.4 B | $ 135.32 | -0.64 % | $ 21.5 B | ||
|
Charles River Laboratories International
CRL
|
8.54 B | $ 203.16 | 0.14 % | $ 10.4 B | ||
|
ENDRA Life Sciences
NDRA
|
2.2 M | $ 5.1 | - | $ 2.74 M | ||
|
Pacific Biosciences of California
PACB
|
1.41 B | $ 1.88 | 3.3 % | $ 477 M | ||
|
PerkinElmer
PKI
|
14.1 B | - | -0.91 % | $ 14.7 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 B | $ 175.92 | 0.48 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
92.1 M | $ 6.82 | 1.04 % | $ 884 M | ||
|
Myriad Genetics
MYGN
|
973 M | $ 6.55 | -0.15 % | $ 593 M | ||
|
Laboratory Corporation of America Holdings
LH
|
21.1 B | $ 254.46 | 0.52 % | $ 21.3 B | ||
|
ICON Public Limited Company
ICLR
|
16.6 B | $ 183.68 | 0.33 % | $ 15.2 B | ||
|
IDEXX Laboratories
IDXX
|
37.7 B | $ 688.18 | 0.86 % | $ 56.8 B |